Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2016 | 1 |
2017 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.
N Engl J Med. 2017.
PMID: 28002688
Free article.
Clinical Trial.
Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS).
Tsivgoulis G, Deftereos S, Gobbi C, Gulowsen Celius E, Kulakowska A, Maniscalco G, Mendes I, Grigoriadis N.
Tsivgoulis G, et al. Among authors: gulowsen celius e.
J Cent Nerv Syst Dis. 2022 Apr 1;14:11795735211069441. doi: 10.1177/11795735211069441. eCollection 2022.
J Cent Nerv Syst Dis. 2022.
PMID: 35392050
Free PMC article.
Item in Clipboard
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.
Damotte V, Guillot-Noel L, Patsopoulos NA, Madireddy L, El Behi M; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2; De Jager PL, Baranzini SE, Cournu-Rebeix I, Fontaine B.
Damotte V, et al.
Genes Immun. 2014 Mar;15(2):126-32. doi: 10.1038/gene.2013.70. Epub 2014 Jan 16.
Genes Immun. 2014.
PMID: 24430173
Free article.
Item in Clipboard
Cite
Cite